Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Ozieranski, Piotr
McKee, Martin
and
King, Lawrence
2012.
The politics of health technology assessment in Poland.
Health Policy,
Vol. 108,
Issue. 2-3,
p.
178.
Godman, Brian
Malmström, Rickard E
Diogene, Eduardo
Gray, Andy
Jayathissa, Sisira
Timoney, Angela
Acurcio, Francisco
Alkan, Ali
Brzezinska, Anna
Bucsics, Anna
Campbell, Stephen M
Czeczot, Jadwiga
de Bruyn, Winnie
Eriksson, Irene
Yusof, Faridah Aryani Md
Finlayson, Alexander E
Fürst, Jurij
Garuoliene, Kristina
Guerra Júnior, Augusto
Gulbinovič, Jolanta
Jan, Saira
Joppi, Roberta
Kalaba, Marija
Magnisson, Einar
McCullagh, Laura
Miikkulainen, Kaisa
Ofierska-Sujkowska, Gabriela
Pedersen, Hanne Bak
Selke, Gisbert
Sermet, Catherine
Spillane, Susan
Supian, Azuwana
Truter, Ilse
Vlahović-Palčevski, Vera
Vien, Low Ee
Vural, Elif H
Wale, Janet
Władysiuk, Magdałene
Zeng, Wenjie
and
Gustafsson, Lars L
2015.
Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?.
Expert Review of Clinical Pharmacology,
Vol. 8,
Issue. 1,
p.
77.
McKee, Martin
2015.
Reflecting on ‘European policymaking on the tobacco advertising ban: the importance of escape routes’.
Health Economics, Policy and Law,
Vol. 10,
Issue. 4,
p.
437.
Md Rezal, Rabiatul Salmi
Hassali, Mohamed Azmi
Alrasheedy, Alian A
Saleem, Fahad
Md Yusof, Faridah Aryani
and
Godman, Brian
2015.
Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature.
Expert Review of Anti-infective Therapy,
Vol. 13,
Issue. 5,
p.
665.
Mulinari, Shai
2016.
Regulating Pharmaceutical Industry Marketing: Development, Enforcement, and Outcome of Marketing Rules.
Sociology Compass,
Vol. 10,
Issue. 1,
p.
74.
Kaló, Zoltán
Gheorghe, Adrian
Huic, Mirjana
Csanádi, Marcell
and
Kristensen, Finn Boerlum
2016.
HTA Implementation Roadmap in Central and Eastern European Countries.
Health Economics,
Vol. 25,
Issue. S1,
p.
179.
Ozierański, Piotr
and
King, Lawrence
2016.
The persistence of cliques in the post‐communist state. The case of deniability in drug reimbursement policy in Poland.
The British Journal of Sociology,
Vol. 67,
Issue. 2,
p.
216.
Azzopardi-Muscat, Natasha
Schroder-Bäck, Peter
and
Brand, Helmut
2017.
The European Union Joint Procurement Agreement for cross-border health threats: what is the potential for this new mechanism of health system collaboration?.
Health Economics, Policy and Law,
Vol. 12,
Issue. 1,
p.
43.
Makowska, Marta
and
Dangal, Ganesh
2017.
Polish physicians’ cooperation with the pharmaceutical industry and its potential impact on public health.
PLOS ONE,
Vol. 12,
Issue. 9,
p.
e0184862.
Lipska, Iga
McAuslane, Neil
Leufkens, Hubert
and
Hövels, Anke
2017.
A DECADE OF HEALTH TECHNOLOGY ASSESSMENT IN POLAND.
International Journal of Technology Assessment in Health Care,
Vol. 33,
Issue. 3,
p.
350.
Ozieranski, Piotr
and
King, Lawrence Peter
2017.
Governing drug reimbursement policy in Poland: The role of the state, civil society, and the private sector.
Theory and Society,
Vol. 46,
Issue. 6,
p.
577.
Löblová, Olga
2018.
Who’s afraid of institutionalizing health technology assessment (HTA)?: Interests and policy positions on HTA in the Czech Republic.
Health Economics, Policy and Law,
Vol. 13,
Issue. 2,
p.
137.
Vilhelmsson, Andreas
and
Mulinari, Shai
2018.
Pharmaceutical lobbying and pandemic stockpiling of Tamiflu: a qualitative study of arguments and tactics.
Journal of Public Health,
Vol. 40,
Issue. 3,
p.
646.
Ozierański, Piotr
Löblová, Olga
Nicholls, Natalia
Csanádi, Marcell
Kaló, Zoltán
McKee, Martin
and
King, Lawrence
2019.
Transparency in practice: Evidence from ‘verification analyses’ issued by the Polish Agency for Health Technology Assessment in 2012–2015.
Health Economics, Policy and Law,
Vol. 14,
Issue. 2,
p.
182.
Csanádi, Marcell
Löblová, Olga
Ozierański, Piotr
Harsányi, András
Kaló, Zoltán
McKee, Martin
and
King, Lawrence
2019.
When health technology assessment is confidential and experts have no power: the case of Hungary.
Health Economics, Policy and Law,
Vol. 14,
Issue. 2,
p.
162.
Csanádi, Marcell
Ozierański, Piotr
Löblová, Olga
King, Lawrence
Kaló, Zoltán
and
Botz, Lajos
2019.
Shedding light on the HTA consultancy market: Insights from Poland.
Health Policy,
Vol. 123,
Issue. 12,
p.
1237.
Madureira Lima, Joana
and
Galea, Sandro
2019.
The Corporate Permeation Index – A tool to study the macrosocial determinants of Non-Communicable Disease.
SSM - Population Health,
Vol. 7,
Issue. ,
p.
100361.
Inotai, András
Tomek, Dominik
Niewada, Maciej
Lorenzovici, László
Kolek, Martin
Weber, Jakub
Kurrat, Anne-Katrin
Kiss, Emese Virág
and
Kaló, Zoltán
2020.
Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries.
Frontiers in Pharmacology,
Vol. 11,
Issue. ,
Löblová, Olga
Trayanov, Trayan
Csanádi, Marcell
and
Ozierański, Piotr
2020.
The Emerging Social Science Literature on Health Technology Assessment: A Narrative Review.
Value in Health,
Vol. 23,
Issue. 1,
p.
3.
Rickard, Emily
Ozieranski, Piotr
and
Lexchin, Joel
2021.
A hidden web of policy influence: The pharmaceutical industry’s engagement with UK’s All-Party Parliamentary Groups.
PLOS ONE,
Vol. 16,
Issue. 6,
p.
e0252551.